971 resultados para Sallust, 86 B.C.-34 B.C.


Relevância:

100.00% 100.00%

Publicador:

Resumo:

Resumen en inglés

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Se destaca que la elección de una u otra técnica de trabajo o de varias en las mismas sesiones de grupo está condicionada a la consecución de unos objetivos marcados por los Centros de Colaboración Pedagógica. En este sentido, se describen algunas de las formas del trabajo de grupo y las distintas fases por las que pasa este modo de trabajar.

Second report drawn up on behalf of the Committee on Agriculture, Fisheries and Food. A. on the proposals from the Commission of the European Communities to the Council (COM(84) 515 final - Doc. 2-629/84) for: I. a regulation amending Regulation (EEC) No. 337/79 on the common organization of the market in wine; II. a regulation amending Regulation (EEC) No. 338/79 Laying down special provisions relating to quality wines produced in specified regions; III. a regulation introducing a derogation to the scheme provided for in Regulation (EEC) No. 456/80 on the granting of temporary and permanent abandonment premiums in respect of certain areas under vines and of premiums for the renunciation of replanting; IV. a regulation on the granting for the 1985/86-1989/90 wine years of permanent abandonment premiums in respect of certain areas under vines. B. on the amendment to the proposal from the Commission of the European Communities to the Council (COM(84) 539 final- Doc. 2-780/84) for a regulation amending Regulation (EEC) No. 337/79 on the common organization of the market in wine (COM(84) 515 final of 12.9.1984). C. on the proposals from the Commission of the European Communities to the Council (COM(84) 714 final - Doc. 2-1447/84) for: I. an amendment to the proposal for a regulation amending Regulation (EEC) No. 337/79 on the common organization of the market in wine (COM(84) 515 final and COM(84) 539 final); II. an amendment to the proposal for a regulation amending Regulation (EEC) No. 338/79 Laying down special provisions relating to quality wines produced in specified regions (COM(84) 515 final). D. on the proposal from the Commission of the European Communities to the Council (COM(84) 775 final - Doc. 2-1481/84) for a third amendment to the proposal for a regulation amending Regulation (EEC) No. 337/79 on the common organization of the market in wine. Working Documents 1984-85, Document 2-1575/84, 5 February 1985

Relevância:

100.00% 100.00%

Publicador:

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Com o objetivo de contribuir para um melhor conhecimento do envolvimento das infecções pelos vírus das hepatites B e C, na etioepidemiologia do CHC na Amazônia Oriental, estudou-se 36 pacientes em Belém-PA. Foram avaliados marcadores sorológicos e a pesquisa do HBV-DNA e HCV-RNA pela reação em cadeia da polimerase. Observou-se etilismo em 33,3% e cirrose em 83,3%. Marcadores sorológicos das infecções pelo HBV e HCV foram encontrados respectivamente em 88,9% e 8,3%. O HBsAg foi encontrado em 58,3%; anti-HBc em 86%; anti-HBe em 85,7; HBeAg em 9,5%; anti-HBc IgM em 57,1%. O HBV-DNA foi detectado em 37,7% e em 65% dos HBsAg positivos; o HCV-RNA em 8,5% e em 100% dos anti-HCV positivos. AFP esteve alterada em 88,9% e acima de 400ng/ml em 75% dos casos. Conclui-se que a infecção pelo HBV parece ter importância na etiologia do CHC e ressalta-se a importância de implementar programas de vacinação e detecção precoce do tumor.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Leprosy and hepatitis B virus (HBV) are highly endemic in some regions of the state of Mato Grosso, in central Brazil. The association of leprosy with HBV and hepatitis C virus (HCV) was assessed using a seroprevalence study and 191 leprosy outpatients were included. Demographic data and the clinical classification of leprosy were recorded. Evidence of previous HBV infection was present in 53 patients (27.7%, 95% confidence interval: 21.9-34.5) and two (1%) were HBsAg positive. Five (2.6%) had antibodies to HCV. The prevalence of previous exposure to HBV was higher than expected for an adult population in central Brazil. In contrast, the prevalence of anti-HCV antibodies was not much higher regarding the age range of participants. HBV markers were associated with a higher number of sex partners and the use of injections without proper sterilisation of the syringes. The number of HBV carriers was small, suggesting that there was no increased likelihood of chronification among these patients.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections pose major public health problems because of their prevalence worldwide. Consequently, screening for these infections is an important part of routine laboratory activity. Serological and molecular markers are key elements in diagnosis, prognosis and treatment monitoring for HBV and HCV infections. Today, automated chemiluminescence immunoassay (CLIA) analyzers are widely used for virological diagnosis, particularly in high-volume clinical laboratories. Molecular biology techniques are routinely used to detect and quantify viral genomes as well as to analyze their sequence; in order to determine their genotype and detect resistance to antiviral drugs. Real-time PCR, which provides high sensitivity and a broad dynamic range, has gradually replaced other signal and target amplification technologies for the quantification and detection of nucleic acid. The next-generation DNA sequencing techniques are still restricted to research laboratories.The serological and molecular marker methods available for HBV and HCV are discussed in this article, along with their utility and limitations for use in Chronic Hepatitis B (CHB) diagnosis and monitoring.

Relevância:

90.00% 90.00%

Publicador:

Resumo:

A serological survey of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections was carried out on a random sex- and age-stratified sample of 1006 individuals aged 25-64 years in the Seychelles islands. Anti-HBc and anti-HCV antibodies were detected using commercially available enzyme-linked immunosorbent assays (ELISA), followed by a Western blot assay in the case of a positive result for anti-HCV. The age-adjusted seroprevalence of anti-HBc antibodies was 8.0% (95% CI: 6.5-9.9%) and the percentage prevalence among males/females increased from 7.0/3.1 to 19.1/13.4 in the age groups 25-34 to 55-64 years, respectively. Two men and three women were positive for anti-HCV antibodies, with an age-adjusted seroprevalence of 0.34% (95% CI: 0.1-0.8%). Two out of these five subjects who were positive for anti-HCV also had anti-HBc antibodies. The seroprevalence of anti-HBc was significantly higher in unskilled workers, persons with low education, and heavy drinkers. The age-specific seroprevalence of anti-HBc in this population-based survey, which was conducted in 1994, was approximately three times lower than in a previous patient-based survey carried out in 1979. Although there are methodological differences between the two surveys, it is likely that the substantial decrease in anti-HBc prevalence during the last 15 years may be due to significant socioeconomic development and the systematic screening of blood donors since 1981. Because hepatitis C virus infections are serious and the cost of treatment is high, the fact that the prevalence of anti-HCV antibodies is at present low should not be an argument for not screening blood donors for anti-HCV and eliminating those who are positive.